Lymphedema Treatment Act
WOCN Participates in Lymphedema Treatment Act Hill Day
A WOCN Society representative attended the annual Capitol Hill Day on March 2nd in support of the Lymphedema Treatment Act (S.518), introduced by Maria Cantwell (D-WA) and Todd Young (R-IN) in the Senate, and in the House (H.R. 1948), introduced by Rep. Jan Schakowsky (D-IL). The Senate bill currently has 70 cosponsors and the House bill has 382 cosponsors.
The House of Representatives passed H.R. 3, The Elijah E. Cummings Lower Drug Costs Now Act, in late 2019 which would allow the federal government to negotiate prescription drug prices with manufacturers. This new drug pricing system would provide the federal government with significant cost savings. H.R. 3 proposes to use the savings to increase a number of Medicare benefits including adding vision, dental, and hearing benefits to Part B.
In addition, H.R. 3 would add Medicare coverage for compression therapy of lymphedema. The language included in H.R. 3 is based on the WOCN-supported Lymphedema Treatment Act and is a huge win for beneficiaries. House passage of this legislation is an important step, but is only part of the solution as the Senate still needs to act on these provisions before they can be sent to the President. As this point, the Senate has no plans to take up H.R. 3 as they are pursing separate legislation to address prescription drug pricing. However, by passing one chamber of Congress we are hopeful that the Lymphedema Treatment Act will be moved separately in the Senate and then sent to the President.